BioVie closes registered direct offering raising $3.24M gross proceeds at $2.83/share

BIOVIE INC.

Closed registered direct offering of 1,146,000 shares at $2.83/share, gross proceeds ~$3.24M.
Net proceeds after fees of ~$419K are approx. $2.82M; funds for working capital and corporate purposes.
ThinkEquity acted as sole placement agent; offering made under shelf registration S-3.
BioVie is a clinical-stage company developing therapies for liver disease and neurological disorders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.